Octamoxin
Octamoxin (trade names Ximaol, Nimaol), also known as 2-octylhydrazine, is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine class that was used as an antidepressant in the 1960s but is now no longer marketed.[2][3][4][5]
Names | |
---|---|
Preferred IUPAC name
1-Methylheptylhydrazine | |
Systematic IUPAC name
Octan-2-ylhydrazine[1] | |
Identifiers | |
CAS Number |
|
3D model (JSmol) |
|
ChemSpider | |
PubChem CID |
|
UNII | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula |
C8H20N2 |
Molar mass | 144.262 g·mol−1 |
Density | 0.831 g/mL |
Boiling point | 228 °C (442 °F; 501 K) |
Pharmacology | |
Oral | |
Related compounds | |
Related compounds |
Tuaminoheptane |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references |
See also
References
- "Octamoxin - Compound Summary". USA: National Center for Biotechnology Information. 26 March 2005. Identification and Related Records. Retrieved 31 May 2012.
- Ganellin, C. R.; Triggle, David J. (21 November 1996). Dictionary of pharmacological agents - Google Books. ISBN 9780412466304.
- "13-06781. Octamoxin [Archived]: The Merck Index".
- Levy J, Michel-Ber E (1966). "[Relations between the antidepressive effects of octamoxine revealed by 3 pharmacological tests and inhibition of cerebral monoamine oxidase in mice]". Thérapie (in French). 21 (4): 929–45. PMID 5925088.
- Gayral L, Stern H, Puyuelo R (1966). "[Indications and results of the treatment of mental depression by octamoxine (ximaol)]". Thérapie (in French). 21 (5): 1183–90. PMID 5976767.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.